Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1 1

Status

Completed 3

Sponsor Class

INDUSTRY 3OTHER 1NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 2Gynecologic 1

Conditions

Neoplasms 805Carcinoma, Non-Small-Cell Lung 766Breast Neoplasms 731Neoplasm Metastasis 340Colorectal Neoplasms 339Prostatic Neoplasms 324Multiple Myeloma 309Melanoma 305Recurrence 237Ovarian Neoplasms 236Leukemia, Myeloid, Acute 236Lymphoma, Non-Hodgkin 213Lung Neoplasms 211Carcinoma, Renal Cell 200Lymphoma 189Lymphoma, Follicular 163Pancreatic Neoplasms 157Leukemia, Lymphocytic, Chronic, B-Cell 149Carcinoma, Hepatocellular 140Stomach Neoplasms 137Leukemia 133Head and Neck Neoplasms 128Lymphoma, Large B-Cell, Diffuse 126Parkinson Disease 4, Autosomal Dominant Lewy Body 119Squamous Cell Carcinoma of Head and Neck 110Urinary Bladder Neoplasms 109Carcinoma 101Small Cell Lung Carcinoma 99Triple Negative Breast Neoplasms 97Glioblastoma 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Has results × Atypical Squamous Cells of the Cervix × Clear all
NCT00896480 2021-04-08

Study of GSK2132231A Antigen-Specific Cancer Immunotherapeutic in Patients With Inoperable Metastatic Cutaneous Melanoma

GlaxoSmithKline

Phase 2 Completed
24 enrolled 26 charts
Dermatologic

Melanoma, Atypical Squamous Cells of the Cervix

NCT01149343 2020-11-20

Evaluation of a New Vaccine Treatment for Patients With Metastatic Skin Cancer

GlaxoSmithKline

Phase 1 Completed
107 enrolled 20 charts
Dermatologic

Melanoma, Atypical Squamous Cells of the Cervix

NCT00973362 2017-01-06

Clinical Evaluation of the APTIMA® HPV Assay Using the TIGRIS® System

Gen-Probe, Incorporated

Phase 3 Completed
12,896 enrolled 11 charts
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections, Atypical Squamous Cells of the Cervix

Data powered by HemOnc (CC BY 4.0) Colophon ⚡